PharmaSecure at PatientSafe India in June ’16

(An Official publication of PharmaSecure)

PharmaSecure was proud to support PatientSafe India, held in Mumbai in June, focusing on tackling the drug counterfeiting challenge in India and beyond.  CEO Nakul Pasricha shared his views at the conference, highlighting the ways that anti-counterfeiting initiatives can be leveraged for patient engagement and adherence, turning a perceived problem into a business opportunity.

Why PatientSafe India Matters

PatientSafe India involves focused industry forums that bring together key stakeholders from the pharmaceutical ecosystem including manufacturers, regulators, technology, healthcare professionals, trade bodies, etc to tackle patient safety issues and enhance patient safety. Drug counterfeit is one challenge which is gaining notoriety and which takes away the trust of the patient, patient outcomes and poses public safety risk.

Mumbai is a major city for India’s pharmaceutical and healthcare industries.  The event aimed to generate a meaningful dialogue on how to ensure the quality of medicines and strengthen the integrity of the supply-chain not just in India but also in global markets.

Industry Focus: Tackling Drug Counterfeiting

Counterfeit drugs are a global challenge, especially in developing countries with a complex supply chain. PatientSafe India is an event that helps in raising awareness about.

• The overall magnitude and consequences of bogus pharmaceutical products to the health of patients.
• The role of technology in securing pharmaceutical supply chains
• The importance of collaboration between industry, regulators, and healthcare providers

These key subjects contribute to the goal of ensuring that patients get medicines that are safe, authentic, and effective.

PharmaSecure’s Perspective and Contribution

PharmaSecure’s presence at PatientSafe India strengthened the conviction that anti-counterfeiting solutions can bring added value beyond mere compliance. Medicine verification through digital authentication can become an instant patient engagement channel for pharmaceutical companies.

Nakul Pasricha shared insights at the conference about how authentication technologies can.

• Create confidence and transparency between brands and patients.
• Use timely information and reminders to support medication adherence.
• Help drug makers turn safety initiatives into strategic opportunities.

Looking Ahead

PatientSafe India is an initiative that can foster a safer pharmaceutical environment through knowledge-sharing. As regulatory expectations alter and patients become more digitally connected, such forums will work towards shaping the future of patient safety, engagement and trust.

Organizations affirm their commitment to the protection of patients while enabling innovations across the healthcare value chain by supporting such initiatives.

Frequently Asked Questions (FAQs)

1. What was the main objective of PatientSafe India?

PatientSafe India planned to tackle the escalating problem of drug counterfeiting through the collaboration of the pharmaceuticals and healthcare sectors, government regulators, and tech suppliers as well as the discussion of trust and safety solutions aimed at the patients.

2. When and where was PatientSafe India held?

In June 2016, PatientSafe India took place in Mumbai and it was an important venue for talking about the security of pharmaceuticals and the patient-centered innovations not only in India but worldwide.

3. What role did PharmaSecure play at the event?

PharmaSecure not only sponsored but also participated very much in the discussion concerning the fight against fake drugs by implementing technology-based anti-counterfeiting solutions at the PatientSafe India conference.

4. What key message did Nakul Pasricha share at the conference?

Nakul Pasricha laid stress that rather than considering anti-counterfeiting initiatives only as compliance measures, they should be looked upon as opportunities to enhance patient engagement and medication adherence, which in turn would lead to business value creation and at the same time protect the patients.

5. Why are anti-counterfeiting initiatives important for patient engagement?

The measures taken against counterfeiting not only secure the delivery of genuine drugs to patients but also facilitate the personal communication of pharmaceutical companies with patients. Such communication can be a source of better understanding, trust, and, thus, adherence to the prescribed treatments.